A Global, Multicenter Study to Assess Maternal, Fetal and Infant Outcomes of Exposure to Palynziq® (pegvaliase) During Pregnancy and Breastfeeding (PALomino) First published 05/12/2022 Last updated 17/06/2024 EU PAS number:EUPAS35156 Study Ongoing